A Comparison Study of Staging Systems for Bone Sarcomas

Robert Heck, G. Scott Stacy, Michael J. Flaherty, Anthony G. Montag, Terrance D. Peabody, Michael A. Simon

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A retrospective study of 250 patients treated at one institution was done to evaluate the prognostic significance of the new American Joint Committee on Cancer staging system compared with the Musculoskeletal Tumor Society staging system for patients with sarcomas of bone. Regarding the Musculoskeletal Tumor Society system, there were significant differences in survival among patients with Stage I, Stage II, and Stage III disease. There were no significant differences between patients with Stages I-A and I-B disease, nor between patients with Stages II-A and II-B disease. Similarly, regarding the new American Joint Committee on Cancer staging system, there were significant differences among patients with Stage I, Stage II, and Stage IV disease. No significant differences were seen between patients with Stages I-A and I-B disease, between patients with Stages II-A and II-B disease, nor between patients with Stages IV-A and IV-B disease. A significant advantage in the ability to predict prognosis for one staging system over the other staging system was not shown with the relatively small number of patients in this study.

Original languageEnglish (US)
Pages (from-to)64-71
Number of pages8
JournalClinical Orthopaedics and Related Research
Issue number415
DOIs
StatePublished - Jan 1 2003

Fingerprint

Sarcoma
Bone and Bones
Neoplasm Staging
Retrospective Studies
Survival

All Science Journal Classification (ASJC) codes

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Heck, R., Stacy, G. S., Flaherty, M. J., Montag, A. G., Peabody, T. D., & Simon, M. A. (2003). A Comparison Study of Staging Systems for Bone Sarcomas. Clinical Orthopaedics and Related Research, (415), 64-71. https://doi.org/10.1097/01.blo.0000093898.12372.6c

A Comparison Study of Staging Systems for Bone Sarcomas. / Heck, Robert; Stacy, G. Scott; Flaherty, Michael J.; Montag, Anthony G.; Peabody, Terrance D.; Simon, Michael A.

In: Clinical Orthopaedics and Related Research, No. 415, 01.01.2003, p. 64-71.

Research output: Contribution to journalArticle

Heck, Robert ; Stacy, G. Scott ; Flaherty, Michael J. ; Montag, Anthony G. ; Peabody, Terrance D. ; Simon, Michael A. / A Comparison Study of Staging Systems for Bone Sarcomas. In: Clinical Orthopaedics and Related Research. 2003 ; No. 415. pp. 64-71.
@article{4291eca37ca54a3bb66f9f5552000e58,
title = "A Comparison Study of Staging Systems for Bone Sarcomas",
abstract = "A retrospective study of 250 patients treated at one institution was done to evaluate the prognostic significance of the new American Joint Committee on Cancer staging system compared with the Musculoskeletal Tumor Society staging system for patients with sarcomas of bone. Regarding the Musculoskeletal Tumor Society system, there were significant differences in survival among patients with Stage I, Stage II, and Stage III disease. There were no significant differences between patients with Stages I-A and I-B disease, nor between patients with Stages II-A and II-B disease. Similarly, regarding the new American Joint Committee on Cancer staging system, there were significant differences among patients with Stage I, Stage II, and Stage IV disease. No significant differences were seen between patients with Stages I-A and I-B disease, between patients with Stages II-A and II-B disease, nor between patients with Stages IV-A and IV-B disease. A significant advantage in the ability to predict prognosis for one staging system over the other staging system was not shown with the relatively small number of patients in this study.",
author = "Robert Heck and Stacy, {G. Scott} and Flaherty, {Michael J.} and Montag, {Anthony G.} and Peabody, {Terrance D.} and Simon, {Michael A.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1097/01.blo.0000093898.12372.6c",
language = "English (US)",
pages = "64--71",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "415",

}

TY - JOUR

T1 - A Comparison Study of Staging Systems for Bone Sarcomas

AU - Heck, Robert

AU - Stacy, G. Scott

AU - Flaherty, Michael J.

AU - Montag, Anthony G.

AU - Peabody, Terrance D.

AU - Simon, Michael A.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - A retrospective study of 250 patients treated at one institution was done to evaluate the prognostic significance of the new American Joint Committee on Cancer staging system compared with the Musculoskeletal Tumor Society staging system for patients with sarcomas of bone. Regarding the Musculoskeletal Tumor Society system, there were significant differences in survival among patients with Stage I, Stage II, and Stage III disease. There were no significant differences between patients with Stages I-A and I-B disease, nor between patients with Stages II-A and II-B disease. Similarly, regarding the new American Joint Committee on Cancer staging system, there were significant differences among patients with Stage I, Stage II, and Stage IV disease. No significant differences were seen between patients with Stages I-A and I-B disease, between patients with Stages II-A and II-B disease, nor between patients with Stages IV-A and IV-B disease. A significant advantage in the ability to predict prognosis for one staging system over the other staging system was not shown with the relatively small number of patients in this study.

AB - A retrospective study of 250 patients treated at one institution was done to evaluate the prognostic significance of the new American Joint Committee on Cancer staging system compared with the Musculoskeletal Tumor Society staging system for patients with sarcomas of bone. Regarding the Musculoskeletal Tumor Society system, there were significant differences in survival among patients with Stage I, Stage II, and Stage III disease. There were no significant differences between patients with Stages I-A and I-B disease, nor between patients with Stages II-A and II-B disease. Similarly, regarding the new American Joint Committee on Cancer staging system, there were significant differences among patients with Stage I, Stage II, and Stage IV disease. No significant differences were seen between patients with Stages I-A and I-B disease, between patients with Stages II-A and II-B disease, nor between patients with Stages IV-A and IV-B disease. A significant advantage in the ability to predict prognosis for one staging system over the other staging system was not shown with the relatively small number of patients in this study.

UR - http://www.scopus.com/inward/record.url?scp=0142166165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142166165&partnerID=8YFLogxK

U2 - 10.1097/01.blo.0000093898.12372.6c

DO - 10.1097/01.blo.0000093898.12372.6c

M3 - Article

SP - 64

EP - 71

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 415

ER -